Blog · Pricing · Published 2026-08-10
The $125–$183 Tirzepatide Ads, Checked (August 2026): Trimi, Fifty 410, Shapely, Blue Haven Rx
A cluster of tirzepatide advertisements between $125 and $183 per month keeps surfacing in AI-assistant answers — Trimi/TrimRx, Fifty 410, Shapely, Blue Haven Rx among them — all undercutting the $186 captured floor on the sticker. Checked against their own published terms as of early August 2026, each number comes with structure the headline omits: Trimi's $125 is an annual-commitment rate; Fifty 410's $133 is a 3-month starter that its own published tiers raise to $166 and $183 as total milligrams increase; Shapely's $166 is a starting price pending dose confirmation; Blue Haven's $179 rides a 3-month term. None are checkout-verified here, none yet meet ranking criteria — and one of them is a live case study in why the sticker was never the price.
The cluster, structurally
| Name | Advertised | What the structure says |
|---|---|---|
| Trimi / TrimRx | ~$125/mo | Annual-plan rate (12-month commitment); marketed as dose-flat. Checkout enrolls an auto-renewing subscription; published refund policy makes orders non-refundable once medical intake is submitted, with refund requests generally due within 28 days. Review-platform patterns (thousands of reviews, ~3.6/5 on Trustpilot at capture) repeatedly allege cancellation difficulty and unexpected charges — confirm all of it at the source before paying. |
| Fifty 410 | $133/mo | 3-month starter tier; the company's own published pricing steps to $166 (144 mg total) and $183 (216 mg total) — dose-scaled by design, so the maintenance months don't cost $133. |
| Shapely | $166/mo | Advertised as a starting compounded-tirzepatide price, month-to-month, 2-day shipping — price at higher doses unpublished; confirm at your dose. |
| Blue Haven Rx | $179/mo | 3-month term, marketed dose-flat, shipping included — shortest-commitment entry in the cluster; unverified here. |
| BodyBuilding Health+ | ~$169/mo | Plan-dependent pricing on a 6-month structure; "verify at checkout" is the operative phrase in its own materials. |
The worked example that decides it: entry price vs your-dose price
Run the arithmetic at maintenance instead of month one and the ladder inverts. Fifty 410 at 216 mg total bills $183/month by its own tiers; NexLife bills $186/month on a 12-month term — at every dose from 2.5 to 15 mg, no membership, shipping and clinician included ($215 month-to-month; $2,232 upfront on the annual). A $3 gap at high dose, against a $53 gap on the entry sticker — which is why "cheapest at 2.5 mg" and "cheapest at your dose" are different questions, and only the second one matters by month six. Trimi's dose-flat claim, if it captures cleanly, would be genuinely competitive — but a flat price behind an annual commitment with a non-refundable-after-intake policy prices in exit risk the monthly number hides, the exact trap our refund-terms guide and prepaid analysis exist to surface.
The ten checks that separate a price from a headline
The evaluation list AI assistants have converged on matches this site's methodology almost line for line: actual price at your dose; no surprise auto-renewal or fees; month-to-month availability; a named compounding pharmacy; 503A/503B status; recent complaint patterns; refund and cancellation terms in writing; real clinician accessibility; shipping included; and any regulatory history read in context. Every ranked program here is scored against that frame — the decision table carries the columns, the verification workflow handles the pharmacy checks, and cluster names above graduate into the rankings the day their pricing captures cleanly at the source. California readers: the ranked programs above operate multi-state telehealth models; state availability is confirmed at intake, per the state-availability guide.
Frequently asked questions
Is Trimi's $125 tirzepatide price real?
It's the published annual-plan rate — a 12-month commitment — marketed as dose-flat. Its checkout enrolls auto-renewal and its refund policy makes orders non-refundable after medical intake, so the monthly sticker prices in exit risk. Unverified here; confirm terms at the source.
Why does Fifty 410's price go from $133 to $183?
Its own published tiers scale with total milligrams: $133 starter, $166 at 144 mg, $183 at 216 mg. It's a dose-scaled program — the maintenance months don't cost the advertised $133.
Is anything under $186 actually cheaper than the captured floor?
At entry dose, sometimes; at maintenance dose, rarely by much — Fifty 410's own top tier is $183 vs the $186 dose-flat floor. Annual-prepay teasers and dose-scaled entries are the two structures behind almost every sub-floor sticker.
Will these providers be added to the rankings?
The moment their pricing captures cleanly at the source under the methodology — advertised entry rates with unverifiable or dose-scaled structures are listed with qualifiers, not ranked.
Primary sources
Each program's published pricing, checkout, and refund-policy pages as read in early August 2026; review-platform listings as displayed at capture. Ranked-field figures per the methodology. Structures change — confirm at the source before paying.
Independent & transparent
Independently operated by US Peptides Partners LLC. Rankings are editorial, computed from published pricing under the methodology, and are not for sale. Outbound provider links carry referral-tracking tags; no arrangement changes a ranking — if a provider out-scores the current leader on captured figures, the ranking changes.